A citation-based method for searching scientific literature


List of co-cited articles
532 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality.
Susan M Domchek, Tara M Friebel, Christian F Singer, D Gareth Evans, Henry T Lynch, Claudine Isaacs, Judy E Garber, Susan L Neuhausen, Ellen Matloff, Rosalind Eeles,[...]. JAMA 2010
817
3

Clinical evaluation of a multiple-gene sequencing panel for hereditary cancer risk assessment.
Allison W Kurian, Emily E Hare, Meredith A Mills, Kerry E Kingham, Lisa McPherson, Alice S Whittemore, Valerie McGuire, Uri Ladabaum, Yuya Kobayashi, Stephen E Lincoln,[...]. J Clin Oncol 2014
299
3

BRCAPRO validation, sensitivity of genetic testing of BRCA1/BRCA2, and prevalence of other breast cancer susceptibility genes.
Donald A Berry, Edwin S Iversen, Daniel F Gudbjartsson, Elaine H Hiller, Judy E Garber, Beth N Peshkin, Caryn Lerman, Patrice Watson, Henry T Lynch, Susan G Hilsenbeck,[...]. J Clin Oncol 2002
324
3

Cost-effectiveness of population screening for BRCA mutations in Ashkenazi jewish women compared with family history-based testing.
Ranjit Manchanda, Rosa Legood, Matthew Burnell, Alistair McGuire, Maria Raikou, Kelly Loggenberg, Jane Wardle, Saskia Sanderson, Sue Gessler, Lucy Side,[...]. J Natl Cancer Inst 2014
94
3

Prospective study of germline genetic testing in incident cases of pancreatic adenocarcinoma.
Randall Brand, Erkut Borazanci, Virginia Speare, Beth Dudley, Eve Karloski, Mary Linton B Peters, Lindsey Stobie, Nathan Bahary, Herbert Zeh, Amer Zureikat,[...]. Cancer 2018
29
10

DNA-Repair Defects and Olaparib in Metastatic Prostate Cancer.
Joaquin Mateo, Suzanne Carreira, Shahneen Sandhu, Susana Miranda, Helen Mossop, Raquel Perez-Lopez, Daniel Nava Rodrigues, Dan Robinson, Aurelius Omlin, Nina Tunariu,[...]. N Engl J Med 2015
3


Microsatellite Instability Is Associated With the Presence of Lynch Syndrome Pan-Cancer.
Alicia Latham, Preethi Srinivasan, Yelena Kemel, Jinru Shia, Chaitanya Bandlamudi, Diana Mandelker, Sumit Middha, Jaclyn Hechtman, Ahmet Zehir, Marianne Dubard-Gault,[...]. J Clin Oncol 2019
124
3

Risk of cancer other than breast or ovarian in individuals with BRCA1 and BRCA2 mutations.
A Moran, C O'Hara, S Khan, L Shack, E Woodward, E R Maher, F Lalloo, D G R Evans. Fam Cancer 2012
155
3

Disparities in genetic testing: thinking outside the BRCA box.
Michael J Hall, Olufunmilayo I Olopade. J Clin Oncol 2006
115
3

Frequency of mutations in individuals with breast cancer referred for BRCA1 and BRCA2 testing using next-generation sequencing with a 25-gene panel.
Nadine Tung, Chiara Battelli, Brian Allen, Rajesh Kaldate, Satish Bhatnagar, Karla Bowles, Kirsten Timms, Judy E Garber, Christina Herold, Leif Ellisen,[...]. Cancer 2015
249
3

Hereditary cancer predisposition syndromes.
Judy E Garber, Kenneth Offit. J Clin Oncol 2005
318
3

Somatic TP53 variants frequently confound germ-line testing results.
Jeffrey N Weitzel, Elizabeth C Chao, Bita Nehoray, Lily R Van Tongeren, Holly LaDuca, Kathleen R Blazer, Thomas Slavin, D A B M D Facmg, Tina Pesaran, Christina Rybak,[...]. Genet Med 2018
55
5

Germline-focussed analysis of tumour-only sequencing: recommendations from the ESMO Precision Medicine Working Group.
D Mandelker, M Donoghue, S Talukdar, C Bandlamudi, P Srinivasan, M Vivek, S Jezdic, H Hanson, K Snape, A Kulkarni,[...]. Ann Oncol 2019
27
11

Prevalence and characteristics of likely-somatic variants in cancer susceptibility genes among individuals who had hereditary pan-cancer panel testing.
Thomas P Slavin, Bradford Coffee, Ryan Bernhisel, Jennifer Logan, Hannah C Cox, Guido Marcucci, Jeffrey Weitzel, Susan L Neuhausen, Debora Mancini-DiNardo. Cancer Genet 2019
13
23

Germline Mutations in the BRIP1, BARD1, PALB2, and NBN Genes in Women With Ovarian Cancer.
Susan J Ramus, Honglin Song, Ed Dicks, Jonathan P Tyrer, Adam N Rosenthal, Maria P Intermaggio, Lindsay Fraser, Aleksandra Gentry-Maharaj, Jane Hayward, Susan Philpott,[...]. J Natl Cancer Inst 2015
200
3

Rucaparib maintenance treatment for recurrent ovarian carcinoma after response to platinum therapy (ARIEL3): a randomised, double-blind, placebo-controlled, phase 3 trial.
Robert L Coleman, Amit M Oza, Domenica Lorusso, Carol Aghajanian, Ana Oaknin, Andrew Dean, Nicoletta Colombo, Johanne I Weberpals, Andrew Clamp, Giovanni Scambia,[...]. Lancet 2017
561
3

Olaparib tablets as maintenance therapy in patients with platinum-sensitive, relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT-Ov21): a double-blind, randomised, placebo-controlled, phase 3 trial.
Eric Pujade-Lauraine, Jonathan A Ledermann, Frédéric Selle, Val Gebski, Richard T Penson, Amit M Oza, Jacob Korach, Tomasz Huzarski, Andrés Poveda, Sandro Pignata,[...]. Lancet Oncol 2017
656
3

Staging and functional characterization of pheochromocytoma and paraganglioma by 18F-fluorodeoxyglucose (18F-FDG) positron emission tomography.
Henri J L M Timmers, Clara C Chen, Jorge A Carrasquillo, Millie Whatley, Alexander Ling, Graeme Eisenhofer, Kathryn S King, Jyotsna U Rao, Robert A Wesley, Karen T Adams,[...]. J Natl Cancer Inst 2012
154
3

Preoperative genetic testing in pheochromocytomas and paragangliomas influences the surgical approach and the extent of adrenal surgery.
Pavel Nockel, Mustapha El Lakis, Apostolos Gaitanidis, Lily Yang, Roxanne Merkel, Dhaval Patel, Naris Nilubol, Tamara Prodanov, Karel Pacak, Electron Kebebew. Surgery 2018
16
18

European Society of Endocrinology Clinical Practice Guideline for long-term follow-up of patients operated on for a phaeochromocytoma or a paraganglioma.
P F Plouin, L Amar, O M Dekkers, M Fassnacht, A P Gimenez-Roqueplo, J W M Lenders, C Lussey-Lepoutre, O Steichen. Eur J Endocrinol 2016
170
3

The genetic basis of kidney cancer: a metabolic disease.
W Marston Linehan, Ramaprasad Srinivasan, Laura S Schmidt. Nat Rev Urol 2010
460
3

Counselling framework for moderate-penetrance cancer-susceptibility mutations.
Nadine Tung, Susan M Domchek, Zsofia Stadler, Katherine L Nathanson, Fergus Couch, Judy E Garber, Kenneth Offit, Mark E Robson. Nat Rev Clin Oncol 2016
153
3

Limited family structure and BRCA gene mutation status in single cases of breast cancer.
Jeffrey N Weitzel, Veronica I Lagos, Carey A Cullinane, Patricia J Gambol, Julie O Culver, Kathleen R Blazer, Melanie R Palomares, Katrina J Lowstuter, Deborah J MacDonald. JAMA 2007
130
3

Next-Generation Service Delivery: A Scoping Review of Patient Outcomes Associated with Alternative Models of Genetic Counseling and Genetic Testing for Hereditary Cancer.
Jeanna M McCuaig, Susan Randall Armel, Melanie Care, Alexandra Volenik, Raymond H Kim, Kelly A Metcalfe. Cancers (Basel) 2018
27
11

The tubal fimbria is a preferred site for early adenocarcinoma in women with familial ovarian cancer syndrome.
Fabiola Medeiros, Michael G Muto, Yonghee Lee, Julia A Elvin, Michael J Callahan, Colleen Feltmate, Judy E Garber, Daniel W Cramer, Christopher P Crum. Am J Surg Pathol 2006
550
3


A new initiative on precision medicine.
Francis S Collins, Harold Varmus. N Engl J Med 2015
3

Identification of germline genetic mutations in patients with pancreatic cancer.
Erin E Salo-Mullen, Eileen M O'Reilly, David P Kelsen, Asad M Ashraf, Maeve A Lowery, Kenneth H Yu, Diane L Reidy, Andrew S Epstein, Anne Lincoln, Amethyst Saldia,[...]. Cancer 2015
94
3

Ovarian cancer statistics, 2018.
Lindsey A Torre, Britton Trabert, Carol E DeSantis, Kimberly D Miller, Goli Samimi, Carolyn D Runowicz, Mia M Gaudet, Ahmedin Jemal, Rebecca L Siegel. CA Cancer J Clin 2018
850
3

Timing of referral for genetic counseling and genetic testing in patients with ovarian, fallopian tube, or primary peritoneal carcinoma.
Akiva P Novetsky, Kylie Smith, Sheri A Babb, Donna B Jeffe, Andrea R Hagemann, Premal H Thaker, Matthew A Powell, David G Mutch, L Stewart Massad, Israel Zighelboim. Int J Gynecol Cancer 2013
12
25

Report from the National Society of Genetic Counselors service delivery model task force: a proposal to define models, components, and modes of referral.
Stephanie A Cohen, Shanna L Gustafson, Monica L Marvin, Bronson D Riley, Wendy R Uhlmann, S Bonnie Liebers, Julie A Rousseau. J Genet Couns 2012
44
6

Genetic counseling perspective of engagement with urology and primary care.
Colette Hyatt, Jessica Russo, Carey McDougall. Can J Urol 2019
4
75

Interim Results from the IMPACT Study: Evidence for Prostate-specific Antigen Screening in BRCA2 Mutation Carriers.
Elizabeth C Page, Elizabeth K Bancroft, Mark N Brook, Melissa Assel, Mona Hassan Al Battat, Sarah Thomas, Natalie Taylor, Anthony Chamberlain, Jennifer Pope, Holly Ni Raghallaigh,[...]. Eur Urol 2019
45
6

Germline mutations in HOXB13 and prostate-cancer risk.
Charles M Ewing, Anna M Ray, Ethan M Lange, Kimberly A Zuhlke, Christiane M Robbins, Waibhav D Tembe, Kathleen E Wiley, Sarah D Isaacs, Dorhyun Johng, Yunfei Wang,[...]. N Engl J Med 2012
352
3

Germline Mutations in ATM and BRCA1/2 Are Associated with Grade Reclassification in Men on Active Surveillance for Prostate Cancer.
H Ballentine Carter, Brian Helfand, Mufaddal Mamawala, Yishuo Wu, Patricia Landis, Hongjie Yu, Kathleen Wiley, Rong Na, Zhuqing Shi, Jacqueline Petkewicz,[...]. Eur Urol 2019
51
5

NBS1 is a prostate cancer susceptibility gene.
C Cybulski, B Górski, T Debniak, B Gliniewicz, M Mierzejewski, B Masojć, A Jakubowska, J Matyjasik, E Złowocka, A Sikorski,[...]. Cancer Res 2004
111
3

Models of service delivery for cancer genetic risk assessment and counseling.
Angela M Trepanier, Dawn C Allain. J Genet Couns 2014
47
6

Cancers associated with BRCA1 and BRCA2 mutations other than breast and ovarian.
Jacqueline Mersch, Michelle A Jackson, Minjeong Park, Denise Nebgen, Susan K Peterson, Claire Singletary, Banu K Arun, Jennifer K Litton. Cancer 2015
243
3

Clinical practice guidelines for multiple endocrine neoplasia type 1 (MEN1).
Rajesh V Thakker, Paul J Newey, Gerard V Walls, John Bilezikian, Henning Dralle, Peter R Ebeling, Shlomo Melmed, Akihiro Sakurai, Francesco Tonelli, Maria Luisa Brandi. J Clin Endocrinol Metab 2012
556
3

Pathogenic and likely pathogenic variant prevalence among the first 10,000 patients referred for next-generation cancer panel testing.
Lisa R Susswein, Megan L Marshall, Rachel Nusbaum, Kristen J Vogel Postula, Scott M Weissman, Lauren Yackowski, Erica M Vaccari, Jeffrey Bissonnette, Jessica K Booker, M Laura Cremona,[...]. Genet Med 2016
150
3

Hereditary cancer risk assessment in a pediatric oncology follow-up clinic.
Sara Knapke, Rajaram Nagarajan, Judy Correll, Debra Kent, Karen Burns. Pediatr Blood Cancer 2012
59
5

Familial gastric cancer: genetic susceptibility, pathology, and implications for management.
Carla Oliveira, Hugo Pinheiro, Joana Figueiredo, Raquel Seruca, Fátima Carneiro. Lancet Oncol 2015
156
3

A clinical guide to hereditary cancer panel testing: evaluation of gene-specific cancer associations and sensitivity of genetic testing criteria in a cohort of 165,000 high-risk patients.
Holly LaDuca, Eric C Polley, Amal Yussuf, Lily Hoang, Stephanie Gutierrez, Steven N Hart, Siddhartha Yadav, Chunling Hu, Jie Na, David E Goldgar,[...]. Genet Med 2020
45
6

Genetic/Familial High-Risk Assessment: Colorectal Version 1.2016, NCCN Clinical Practice Guidelines in Oncology.
Dawn Provenzale, Samir Gupta, Dennis J Ahnen, Travis Bray, Jamie A Cannon, Gregory Cooper, Donald S David, Dayna S Early, Deborah Erwin, James M Ford,[...]. J Natl Compr Canc Netw 2016
115
3

Reflex immunohistochemistry and microsatellite instability testing of colorectal tumors for Lynch syndrome among US cancer programs and follow-up of abnormal results.
Laura C Beamer, Marcia L Grant, Carin R Espenschied, Kathleen R Blazer, Heather L Hampel, Jeffrey N Weitzel, Deborah J MacDonald. J Clin Oncol 2012
144
2

Guidelines on genetic evaluation and management of Lynch syndrome: a consensus statement by the US Multi-society Task Force on colorectal cancer.
Francis M Giardiello, John I Allen, Jennifer E Axilbund, C Richard Boland, Carol A Burke, Randall W Burt, James M Church, Jason A Dominitz, David A Johnson, Tonya Kaltenbach,[...]. Am J Gastroenterol 2014
260
2

Participation of low-income women in genetic cancer risk assessment and BRCA 1/2 testing: the experience of a safety-net institution.
Ian K Komenaka, Jesse N Nodora, Lisa Madlensky, Lisa M Winton, Meredith A Heberer, Richard B Schwab, Jeffrey N Weitzel, Maria Elena Martinez. J Community Genet 2016
22
9


Identification of individuals at risk for Lynch syndrome using targeted evaluations and genetic testing: National Society of Genetic Counselors and the Collaborative Group of the Americas on Inherited Colorectal Cancer joint practice guideline.
Scott M Weissman, Randall Burt, James Church, Steve Erdman, Heather Hampel, Spring Holter, Kory Jasperson, Matt F Kalady, Joy Larsen Haidle, Henry T Lynch,[...]. J Genet Couns 2012
84
2


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.